atropine has been researched along with 1,1-dimethylheptyl-11-hydroxytetrahydrocannabinol in 1 studies
| Studies (atropine) | Trials (atropine) | Recent Studies (post-2010) (atropine) | Studies (1,1-dimethylheptyl-11-hydroxytetrahydrocannabinol) | Trials (1,1-dimethylheptyl-11-hydroxytetrahydrocannabinol) | Recent Studies (post-2010) (1,1-dimethylheptyl-11-hydroxytetrahydrocannabinol) |
|---|---|---|---|---|---|
| 26,711 | 1,259 | 1,697 | 343 | 5 | 66 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adami, M; Bertini, S; Brown, DR; Coruzzi, G; de Caro, G; Frati, P; Kulkarni-Narla, A; Soldani, G | 1 |
1 other study(ies) available for atropine and 1,1-dimethylheptyl-11-hydroxytetrahydrocannabinol
| Article | Year |
|---|---|
Gastric antisecretory role and immunohistochemical localization of cannabinoid receptors in the rat stomach.
Topics: Animals; Atropine; Cannabinoids; Dronabinol; Gastric Acid; Gastric Mucosa; Hexamethonium; Immunohistochemistry; Male; Muscarinic Antagonists; Nicotinic Antagonists; Pentagastrin; Rats; Rats, Wistar; Receptor, Cannabinoid, CB2; Receptors, Cannabinoid; Receptors, Drug; Vagotomy | 2002 |